What is necessary for periodic review in a CDTM agreement?

In a Clinical Drug Therapy Management (CDTM) agreement, having a plan for periodic review and documentation procedures is essential to ensure that the agreement remains effective and aligns with current standards and practices. This plan helps to regularly assess the performance and outcomes of the CDTM, allowing for adjustments when necessary based on new evidence, changes in patient populations, or updates in regulations.

Documentation procedures are also critical for maintaining accountability and transparency within the collaboration between pharmacists and other healthcare providers. By having a structured approach to periodic reviews, stakeholders can ensure that the CDTM agreement serves its intended purpose and continues to provide optimal patient care.

Other options, such as verbal agreements or simply conducting training sessions, do not encapsulate the comprehensive need for formal evaluation and documentation that a CDTM agreement mandates. Furthermore, stating that no periodic review is needed undermines the necessity for ongoing assessment in a healthcare setting, where patient safety and efficacy of treatment are paramount.